2 research outputs found
Kaplan-Meier curves for the cumulative probabilities of detection of HIV drug resistance-associated mutations (dashed line) and of failing treatment (HIV-RNA≥400 copies/mL while on treatment) in early cART initiators, i.e. within 12 months of the estimated date of HIV seroconversion.
<p>Kaplan-Meier curves for the cumulative probabilities of detection of HIV drug resistance-associated mutations (dashed line) and of failing treatment (HIV-RNA≥400 copies/mL while on treatment) in early cART initiators, i.e. within 12 months of the estimated date of HIV seroconversion.</p
Hazard ratio (HR) k of treatment interruption by duration of HIV infection (as time between HIV seroconversion and cART initiation) and CD4 count at cART initiation.
<p>Hazard ratio (HR) k of treatment interruption by duration of HIV infection (as time between HIV seroconversion and cART initiation) and CD4 count at cART initiation.</p